Results

Nanobiotix SA

01/26/2022 | Press release | Distributed by Public on 01/26/2022 15:24

NANOBIOTIX Announces Publication of New Preclinical Immunotherapy Data Showcasing the Combination Potential of NBTXR3 With anti-PD-1 and anti-CTLA-4 - Form 6-K